These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 7967731
1. Identification of growth factor-responsive acute myelogenous leukemia based on factor-dependence for survival and proliferation. Gore SD, Weng LJ, Burke PJ. Leukemia; 1994 Nov; 8(11):1854-63. PubMed ID: 7967731 [Abstract] [Full Text] [Related]
2. Validation of flow-cytometric determination of Ki67 expression as a measure of growth factor response in acute myelogenous leukemia. Gore SD, Weng LJ, Burke PJ. Exp Hematol; 1993 Dec; 21(13):1702-8. PubMed ID: 7694870 [Abstract] [Full Text] [Related]
3. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Drexler HG. Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433 [Abstract] [Full Text] [Related]
4. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG. Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239 [Abstract] [Full Text] [Related]
5. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD. Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711 [Abstract] [Full Text] [Related]
14. Recombinant human IL-3 and G-CSF act synergistically in stimulating the growth of acute myeloid leukemia cells. Pébusque MJ, Faÿ C, Lafage M, Sempéré C, Saeland S, Caux C, Mannoni P. Leukemia; 1989 Mar; 3(3):200-5. PubMed ID: 2465464 [Abstract] [Full Text] [Related]
15. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor. Delwel R, van Buitenen C, Salem M, Oosterom R, Touw I, Löwenberg B. Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834 [Abstract] [Full Text] [Related]
16. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment]. Gotoh A, Kawanishi Y, Kurosawa K, Miyazawa K, Ohtaka M, Aizawa S, Kimura Y, Yoshikawa O, Toyama K. Rinsho Ketsueki; 1993 Jul; 34(7):821-8. PubMed ID: 7689660 [Abstract] [Full Text] [Related]
17. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines. Santoli D, Yang YC, Clark SC, Kreider BL, Caracciolo D, Rovera G. J Immunol; 1987 Nov 15; 139(10):3348-54. PubMed ID: 3500218 [Abstract] [Full Text] [Related]
18. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P. Leukemia; 1993 Aug 15; 7(8):1191-8. PubMed ID: 7688839 [Abstract] [Full Text] [Related]
19. Product of the Steel locus can replace leukemic cell interaction. Cáceres-Cortés JR, Hoang T. Cancer Res; 1992 Oct 01; 52(19):5208-12. PubMed ID: 1382839 [Abstract] [Full Text] [Related]
20. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. Hu ZB, Ma W, Zaborski M, MacLeod R, Quentmeier H, Drexler HG. Leukemia; 1996 Jun 01; 10(6):1025-40. PubMed ID: 8667638 [Abstract] [Full Text] [Related] Page: [Next] [New Search]